Pierce Valerie L 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Jan 18, 2024
Insider Transaction Report
Form 4
Pierce Valerie L
SVP, GC & CCO
Transactions
- Tax Payment
Common Stock
2024-01-16$1.34/sh−5,021$6,728→ 55,374 total
Footnotes (2)
- [F1]Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.
- [F2]Includes 4,728 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023.